Literature DB >> 24277674

Nonalcoholic fatty liver disease and type 2 diabetes in obese children.

Lior Hecht1, Ram Weiss.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is commonly found in adults and adolescents with type 2 diabetes (T2DM). The cause-effect relations of these 2 conditions are complex and it is difficult to decipher whether one drives the other or vice versa. Genetic predispositions, along with obesity, are probably shared culprits of both. NAFLD may precede the diagnosis of diabetes and play a critical role of driving its development by way of increasing hepatic and whole body insulin resistance. On the other hand, T2DM is associated with hyperinsulinemia, a resistance to some of the effects of gut derived peptides and increased systemic free fatty acids, that can all promote hepatic lipid deposition. Thus, each condition may promote the development of the other and their mutual presence creates a vicious cycle. Upon studying this complex interplay from another angle, reduction of liver fat significantly improves glucose metabolism in patients with T2DM highlighting the tight pathophysiological link between them.

Entities:  

Mesh:

Year:  2014        PMID: 24277674     DOI: 10.1007/s11892-013-0448-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  55 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

2.  Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.

Authors:  Christina Wei; Anna Ford; Linda Hunt; Elizabeth C Crowne; Julian P H Shield
Journal:  Arch Dis Child       Date:  2010-11-19       Impact factor: 3.791

3.  Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Julia Steinberger; Stephen R Daniels; Robert H Eckel; Laura Hayman; Robert H Lustig; Brian McCrindle; Michele L Mietus-Snyder
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

4.  Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.

Authors:  Gianluca Perseghin; Riccardo Bonfanti; Serena Magni; Guido Lattuada; Francesco De Cobelli; Tamara Canu; Antonio Esposito; Paola Scifo; Georgia Ntali; Federica Costantino; Laura Bosio; Francesca Ragogna; Alessandro Del Maschio; Giuseppe Chiumello; Livio Luzi
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-05-09       Impact factor: 4.310

Review 5.  Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

Authors:  K H Williams; N A Shackel; M D Gorrell; S V McLennan; S M Twigg
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

6.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 7.  A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Authors:  Claire Z Larter; Shiv Chitturi; Déborah Heydet; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

8.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

Authors:  Adam B Mayerson; Ripudaman S Hundal; Sylvie Dufour; Vincent Lebon; Douglas Befroy; Gary W Cline; Staffan Enocksson; Silvio E Inzucchi; Gerald I Shulman; Kitt F Petersen
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

Review 9.  Hepatogenous diabetes. Current views of an ancient problem.

Authors:  Diego García-Compean; Joel Omar Jaquez-Quintana; Héctor Maldonado-Garza
Journal:  Ann Hepatol       Date:  2009 Jan-Mar       Impact factor: 2.400

Review 10.  Why young adults hold the key to assessing the obesity epidemic in children.

Authors:  Joyce M Lee
Journal:  Arch Pediatr Adolesc Med       Date:  2008-07
View more
  7 in total

1.  The epidemiology, clinical, biochemical, immunological and radiological features of youth onset type 2 diabetes mellitus in the state of Qatar.

Authors:  Shayma M Ahmed; Basma Haris; Saras Saraswathi; Ahmed Elawwa; Amal Khalifa; Maryam AlMaadheed; Tasneem R Abdel-Karim; Noor Hamed; Houda Afyouni; Hajar Dauleh; Ahmed Shamekh; Mahmoud Al-Zyoud; Fawziya AlKhalaf; Goran Petrovski; Khalid Hussain
Journal:  Diabetol Int       Date:  2021-10-11

2.  Type 2 Diabetes Mellitus in a 7 Year Old Girl.

Authors:  Basma Haris; Samuel Stafrace; Khalid Hussain
Journal:  Int Med Case Rep J       Date:  2022-05-12

3.  Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study.

Authors:  M-C Lacasse; A Tang; J Dubois; F Alvarez; S Spahis; M Chagnon; S Deschênes; E Levy
Journal:  Obes Sci Pract       Date:  2017-01-23

4.  Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet.

Authors:  Miaomiao Jin; Xiaohong Niu; Yan Liu; Dong Zhang; Danni Yuan; Huimin Shen
Journal:  Open Med (Wars)       Date:  2020-07-18

Review 5.  Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.

Authors:  Serena Scapaticci; Ebe D'Adamo; Angelika Mohn; Francesco Chiarelli; Cosimo Giannini
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-06       Impact factor: 5.555

6.  Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.

Authors:  Veronica Marin; Silvia Gazzin; Sabrina E Gambaro; Matteo Dal Ben; Sonia Calligaris; Monica Anese; Alan Raseni; Claudio Avellini; Pablo J Giraudi; Claudio Tiribelli; Natalia Rosso
Journal:  Nutrients       Date:  2017-09-12       Impact factor: 5.717

7.  Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.

Authors:  Jurgen H Runge; Jet van Giessen; Laura G Draijer; Eline E Deurloo; Anne M J B Smets; Marc A Benninga; Bart G P Koot; Jaap Stoker
Journal:  Eur Radiol       Date:  2020-09-10       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.